Active substanceChondroitin sulfateChondroitin sulfate
Similar drugsTo uncover
  • Artogistan
    solution w / m 
    GROTEKS, LLC     Russia
  • ARTRA® Chondroitin
    capsules inwards 
    Unipharm, Inc.     USA
  • Arthravir®-Inkamparm®
    solution w / m 
    TRIVIUM-XXI, LLC     Russia
  • Arthradol®
    lyophilizate w / m 
    Inkamfarm, OOO     Russia
  • ARTRADOL®
    capsules inwards 
    TRIVIUM-XXI, LLC     Russia
  • Artrafic
    ointment externally 
    ATOLL, LLC     Russia
  • DRASTOP
    solution w / m 
  • Mukosat®
    solution w / m 
  • Mukosat®
    ointment externally 
       
  • Teraflex® Hondrokrem Forte
    cream externally 
    BAYER, AO     Russia
  • Hondroguard®
    solution w / m 
  • Chondroitin
    capsules inwards 
    VERTEKS, AO     Russia
  • Chondroitin
    gel externally 
    VERTEKS, AO     Russia
  • Chondroitin
    capsules inwards 
    ATOLL, LLC     Russia
  • Chondroitin sulfate
    lyophilizate w / m 
    ELLARA, LTD.     Russia
  • Chondroitin-Akos
    ointment externally 
    SYNTHESIS, OJSC     Russia
  • Chondroitin-Akos
    capsules inwards 
    SYNTHESIS, OJSC     Russia
  • Chondroitin sulfate
    solution w / m 
    Medimeks, ZAO     Russia
  • Chondroitin sulfate
    solution w / m 
    ELLARA, LTD.     Russia
  • Chondroitin sulfate
    lyophilizate w / m 
  • Chondroitin sulfate
    solution w / m 
    BIOSINTEZ, PAO     Russia
  • Chondroxide®
    ointment externally 
    NIZHFARM, JSC     Russia
  • Chondroxide®
    pills inwards 
    NIZHFARM, JSC     Russia
  • Chondroxide®
    gel externally 
    NIZHFARM, JSC     Russia
  • Chondrolon®
    lyophilizate w / m 
  • Dosage form: & nbspOintment for external use.
    Composition:

    Composition per 100 g of ointment:

    Active substance: chondroitin sodium sulfate (in terms of dry matter) - 5.0 g; Excipients: dimethylsulfoxide (dimexide) - 10.0 g, lanolin (lanolin - anhydrous) -15.0 g, Vaseline (Vaseline medical) - 50.0 g, purified water - up to 100.0 g.

    Description:Ointment is light yellow with the smell of dimethylsulfoxide.
    Pharmacotherapeutic group:Regeneration of tissue stimulant.
    ATX: & nbsp

    M.01.A.X.25   Chondroitin sulfate

    Pharmacodynamics:
    A high molecular weight mucopolysaccharide, which slows the resorption of bone tissue and
    reducing calcium loss. Improves phosphoric-calcium metabolism in cartilaginous tissue,
    accelerates the processes of its recovery, inhibits the processes of degeneration of the cartilaginous and
    connective tissue. Suppresses enzymes that cause damage to cartilaginous tissue, stimulates the synthesis of glycosaminoglycans, promotes the regeneration of the articular bag and the cartilaginous surfaces of the joints, increases the production of intra-articular fluid.Due to its structural proximity to heparin, it prevents formation of fibrin clots in the synovial and subchondral microcirculatory bed. Reduces soreness and increases the mobility of affected joints.
    Slows the progression of osteoarthritis.
    Dimethyl sulfoxide, which is part of the ointment, has anti-inflammatory, analgesic and fibrinolytic effects, promotes better penetration of chondroitin sulfate through cell membranes.
    Pharmacokinetics:Virtually does not have systemic absorption.
    Indications:Degenerative and dystrophic diseases of joints and spine - osteoarthrosis with predominant lesion of large joints intervertebral osteochondrosis.
    Contraindications:Hypersensitivity, violation of the integrity of the skin in places of intended application.
    Carefully:Do not use Chondroitin-AKOS ointment without consulting a doctor during pregnancy and lactation (breastfeeding). Age to 18 years.
    Pregnancy and lactation:During pregnancy and during breastfeeding (lactation) Chondroitin-ACOS ointment is prescribed only after consulting a doctor and with caution, the duration of treatment is determined by the doctor.
    Dosing and Administration:
    OUTSIDE!
    Chondroitin-AKOS ointment is applied 2-3 times a day on the skin over the lesion and rubbed for 2-3 minutes until completely absorbed. The course of treatment is 2-3 weeks. If necessary, repeat the treatment.
    In severe cases, concomitantly prescribe drugs of chondroitin sulfate for oral administration or for intramuscular injection.
    Side effects:In rare cases, allergic reactions are possible, while the drug is canceled. If you notice any other side effects not listed in the instructions, tell your doctor.
    Overdose:When external application of ointment Chondroitin-AKOS overdose is unlikely (due to the lack of systemic absorption of the drug). To date, no cases of an overdose of Chondroitin-AKOS ointment have been reported.
    Interaction:There are no cases of negative drug interaction in prescribing the ointment against the background of therapy with other drugs included in the generally accepted regimens for the treatment of degenerative diseases of the joints and spine.
    Special instructions:
    Avoid contact with ointment on mucous membranes and open wounds.
    Do not use the drug without consulting a doctor before the age of 18.

    Effect on the ability to drive transp. cf.and fur:Chondroitin-AKOS ointment does not affect the ability to drive vehicles and engage in potentially hazardous activities requiring increased concentrated attention and speed of psychomotor reactions.
    Form release / dosage:Ointment for external use 5%.
    Packaging:
    For 30.50 g in aluminum tubes with screwed polymeric buds. 1 tube with instruction for use is placed in a pack of cardboard.
    Storage conditions:
    In the dark place at a temperature of 2 ° C to 20 ° C. Keep out of the reach of children.
    Shelf life:
    3 years. Do not use after the expiry date printed on the package.
    Terms of leave from pharmacies:Without recipe
    Registration number:P N000545 / 01
    Date of registration:01.08.2011
    The owner of the registration certificate:SYNTHESIS, OJSC SYNTHESIS, OJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp28.09.2015
    Illustrated instructions
      Instructions
      Up